Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01469650 · ClinicalTrials.gov registry record · NA
Serum 25-hydroxy Vitamin D [25(OH)D] Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT01469650 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 32 participants.
The verdict
NCT01469650, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study will determine levels of vitamin D supplementation to achieve goal serum 25-hydroxy vitamin D \[25(OH)D\] levels of 30 ng/mL, and to define serum 25(OH)D levels required to achieve suppression of parathyroid hormone in preterm newborn infants hospitalized in Newborn Intensive Care Nursery (NICU). Infants 23 weeks gestational age or greater will be randomized to two different levels of vitamin D supplementation: 400 IU vitamin D3/day, or 800 IU vitamin D3/day.
Interventions
- DIETARY_SUPPLEMENT cholecalciferol
- DIETARY_SUPPLEMENT cholecalciferal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01469650
The ClinicalTrials.gov registry entry for NCT01469650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which cholecalciferol is the first listed.
NCT01469650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01469650 about?
NCT01469650 is a clinical study titled "Serum 25-hydroxy Vitamin D [25(OH)D] Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants". This study will determine levels of vitamin D supplementation to achieve goal serum 25-hydroxy vitamin D \[25(OH)D\] levels of 30 ng/mL, and to define serum 25(OH)D levels required to achieve suppression of parathyroid hormone in preterm newborn infants hospitalized in Newborn Intensive Care Nursery...
What is the current status of trial NCT01469650?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2012-01. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01469650?
The interventions under investigation include: cholecalciferol (DIETARY_SUPPLEMENT), cholecalciferal (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01469650?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.